Expanding regenerative medicine

Treatment for Patients

Implementing the most advanced stem cell research in clinic at our point-of-care facilities.


Solutions for Veterinarians

Providing veterinarians extensive regenerative medicine solutions for their patients.

Training for Physicians

Programs that train physicians to perform Bone Marrow Derived Stem Cell protocols.

Top Scientists

We work with some of the top innovators in the industry to perform research and develop treatments

Full Service

We have offer a wide range of in-clinic regenerative medicine solutions for physicians

Since 1999

We have treated over 10,000 patients and have done many of the first ever indications in the world

Developing the future of medicine

We are focused on the discovery, development and commercialization of cell based therapeutics that prevent, treat or cure disease by repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function. We believe that regenerative medicine / cellular therapeutics will play a large role in positively changing the natural history of diseases ultimately, we contend, lessening patient burdens as well as reducing the associated economic impact disease imposes upon modern society.

Want to learn more about US Stem Cell, Inc?

Why U.S. Stem Cell?

  • We have helped treat over 10,000 patients
  • We have trained over 700 practitioners
  • We have spent more than $125 million in research and development
  • We do not utilize harmful drugs to isolate cells from peripheral blood.
  • We have worked with several countries to help develop and write the regulations for stem cell therapy
  • Our protocols are being utilized in 6 continents
  • We are the inventors and developers of our own therapies

The U.S. Stem Cell Vision

Regenerative medicine can improve the quality of patients’ lives, while reducing hospitalizations and healthcare costs. U.S. Stem Cell is and will continue to be recognized by physicians and patients as the world’s leader in providing innovative treatment and management of patients with severe degenerative conditions.

Latest News